no more compounding glp 1 drugs π¨ FDA Moves to Permanently Shut Down Compounded GLP-1s The FDA is taking steps to eliminate large-scale of GLP-1 medications like semaglutide and tirzepatide, signaling a major shift in how these Decoding GLP-1 Weight Loss Medications
Description
10.1210/jcem.87.3.8355 93 NauckM

However, some studies suggest that these side effects may be slightly more common or intense with tirzepatide, likely due to its dual-agonist action and higher efficacy

doi: 10.1021/acs.jmedchem.5b00726 96 DeaconCFKnudsenLBMadsenKWibergFCJacobsenOHolstJJ

2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults
It also prevents the body from releasing too much glucagon, a hormone that increases blood sugar levels
